Д.Даваадорж
Loading...
Товч нэр
Д.Даваадорж
Бүтэн нэр
Дүгэр Даваадорж
Латин нэр
Duger Davaadorj
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
8 results
Now showing 1 - 8 of 8
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Impact of Combination Direct-Acting Antivirals and Chemotherapy(Mongolian National University of Medical Sciences, 2021-12-31); ;Delgerbat Boldbaatar ;Khishigjargal Batsukh; Objectives: Direct-acting antiviral agents (DAAs) have successfully eradicated chronic hepatitis C virus (HCV) infection. Since chronic HCV is known to have an increased risk of developing B cell non-Hodgkin lymphoma (B-NHL), successful HCV treatment may have virologic, hepatic, and oncologic benefits for B-NHL. Therefore, this study aimed to determine the efficacy of DAAs combined with chemotherapy in B-NHL patients with chronic HCV in Mongolia. Methods: This case-control study included newly diagnosed B-NHL patients with chronic HCV who received DAAs before chemotherapy (with DAAs group). The other is comprised of controls who have been treated by chemotherapy without DAAs. Patients who received courses of DAAs were monitored by the virological and hepatic responses. Results: Eleven patients received DAAs and none of them developed chemotherapy-associated hepatitis flare. Of the DAAs group, during DAAs treatment, 90.9% were clinically stable. In all cases of DAAs in combination with chemotherapy, the Sustained Viral Response (SVR)12 and 24 were 100%. However, 47.4% of those who received DAAs after chemotherapy developed hepatitis flare during chemotherapy. Patients with hepatitis flare had higher serum level of ALT before chemotherapy (15.7 U/L vs. 40.2 U/L; p = 0.014) than those without. Conclusion: DAAs administration results in a significant clinical benefit to B-NHL patients with chronic HCV. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Diagnosis of severe life-threatening decompensated liver cirrhotic complication via cytokines(2022-11-14) ;Bayarmaa Ochirkhuree ;Ayush Khangai; Background: Mongolia is known to be the leading country in the world for liver cancer. The primary cause of liver cancer evidently reported were hepatic virus such as HCV, HBV and HDV. The high mortality of patient with liver cirrhosis is mostly due liver decompensation related complication such as GI bleeding, hepatic failure, infection mostly due to spontaneous bacterial peritonitis (SBP). In this study we aimed to determine the SBP in early stages through examination of cytokines from peritoneal fluid. Methods: Study was conducted among 58 hospitalized patients at the Gastroenterology Center of The FCHM between February to September 2020, who were diagnosed with liver cirrhosis and ascites. Ascites fluid was aspirated following the hospital protocol via abdominal tab with a 16-inch needle guided by ultrasonography on the day 1 of hospitalize and examined for IL-4, IL-6 and INF-gamma. Results: The average age for patients was 52.5 and 31 (53.4%) were males. The hepatic viral cirrhosis was 52 (89.6%). Of the total cases, 28 (48.2%) were CTP-B, and 30 (51.8%) were CTP-C and the mean model for end-stage liver disease score was 20.6. The SBP and non-SBP groups characteristics presented in table 1. Best cut-off value to determine SBP for IL-6 was 629.78 pg/mL with sensitivity and specificity both 100% in Mongolian patients. Conclusions: In patient with liver cirrhosis, elevated IL-6 level (more than 630 pg/mL) in ascites can predict the SBP status as early as possible in limited secondary hospital and to start antibiotic treatment also as early as possible. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Donor’s quality of life after living donor liver transplantation and influencing factors in Mongolia(2022-11-15) ;Munkhzaya Chogsom ;Nasantogtokh Erdenebileg; Background: Improving the quality of living liver donor's postdonation is an important aspect of care quality. In addition, there are many factors that affect the quality of life. In Mongolia, evidence-based information on the quality of life of living donors is few. This study aims to propose the quality of life of living donors who donated organs for liver transplantation and influencing factors. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ходоодны хорт хавдар болон хавдрын бус тохиолдолд Хеликобактер пилори /Helicobacter pylori/-ийн хоруу чанарын генийг харьцуулсан судалгаа(2021-03-21); ;Х.Оюунцэцэг; ; Үндэслэл: Дэлхий дахинд ходоодны хавдрын өвчлөл болон нас баралтаар CagPAIcytotoxin Монгол улс 1-р байранд орж байна1. Хеликобактер пилори (Hp) нь associated gene ходоодны хорт хавдар үүсгэх гол шалтгаан болдог. Өмнөх судалгаанаас pathogenicity island харахад хөгжиж буй орнууд тухайлбал Африкын улс орнууд, Энэтхэг, Хеликобактер пилори Бангладеш зэрэг улс орнуудтай адил Монголчуудын дунд Hp-ийн Ходоодны хавдар халдварын тархалт 70% байгаа нь тогтоогдсон2. Сонирхолтой нь Монгол улс дээрх хөгжиж буй орнуудад Hp-ийн халдварын тархалт өндөр хэдий ч ходоодны хорт хавдрын тохиолдлоор доогуурт ордог нь судлаачдын анхаарлыг ихээр татдаг. Үүнийг CagA хоруу чанарын генийн генотип болон CagA генийг эзэн эс рүү оруулах үүргийг гүйцэтгэдэг CagPAI иж бүрдлийн генүүдийн ялгаатай байдалтай холбон тайлбарладаг. Манай улсад Hp-ийн CagPAI иж бүрдлийн генүүдийн нарийвчилсан судалгаа хийгдээгүй байна. Зорилго: Ходоодны хорт хавдар ба хавдрын бус тохиолдлын үед Hp-ийн CagPAI иж бүрдлийн генүүдийг судлах. Арга аргачлал: Ходоодны биж хам шинж бүхий, 18 наснаас дээш Монгол улсын иргэнийг сайн дурын үндсэн дээр хамруулан ходоодны хавдар ба хавдрын бус тохиолдлуудад ходоодны дуран, ходоодны гистологи шинжилгээ, Хеликобактери пилорийн өсгөвөр, түүний удмын дарааллыг тогтоох агшингийн судалгааг хийж гүйцэтгэсэн. Ходоодны хорт хавдрын оношилгоог Лауренсийн ангилалаар тодорхойлон Hp-ийн халдварыг өсгөвөрлөсний дараа CagPAI иж бүрдлийн генүүдийг илрүүлж статистик боловсруулалт хийсэн. Үр дүн: Судалгаанд хамрагсдын дундаж нас 48 байсан ба хүйсийн харьцаа (эр:эм) 1:1 байв. Ходоодны хорт хавдаргүй 72.22% (n=39), хорт хавдар оношлогдсон 27.77% (n=15) тохиолдол байлаа. Hp-ийн CagPAI иж бүрдэл генийг тодорхойлоход хавдаргүй тохиолдолын 79.5% (n=31)-д CagPAI иж бүрдэл бүрэн байгаа нь тогтоогдсон бол хавдартай тохиолдолд 100% (n=15) илэрсэн (p>0.05) үзүүлэлттэй байлаа. Дүгнэлт: Ходоодны хорт хавдар оношлогдсон үйлчлүүлэгчдийн дунд тархсан Hp-ийн хоруу чанарын CagPAI иж бүрдлийн 26 генүүд бүгд тодорхойлогдож байгаа нь CagA онкоген уураг эзэн эсэд бүрэн нэвтрэн орох чадамжтай байгааг харуулж байна. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Ходоодны хорт хавдрын тохиолдлыг эрт илрүүлэг шинжилгээгээр судалсан үр дүн(2024-01-28) ;Ж.Билгүүн; ;Ц.Сарантуяа ;Х.ОюунцэцэгҮндэслэл: Монгол улс ходоодны хорт хавдрын өвчлөл болон нас баралтын түвшнээрээ дэлхий дахинд тэргүүлсээр байна. Иймд 2022 оноос эхлэн Монгол улсад улаан хоолой ходоодны хорт хавдраас урьдчилан сэргийлэх, эрт илрүүлэх үндэсний хөтөлбөрийг хэрэгжүүлж хүн амын дунд ходоодны хорт хавдрын эрт илрүүлгийн түвшинг тодорхойлох олон төвт судалгааг хийсэн. Зорилго: Ходоодны хавдрын эрт болон хожуу үеийн илрүүлгийн үр дүн, эрт үеийн хавдрын илрүүлэлтийн түвшинг судлах. Арга, аргачлал: 2022 оны 5 дугаар сараас 2023 оны 5 дугаар сарын хооронд буюу 1 жилийн хугацаанд Монгол улсын 28 дурангийн төвд ходоодны дурангийн шинжилгээнд хамрагдсан хүмүүсийн доторх хорт хавдрын урьдал эмгэг (бага түвшинт дисплази, эсийн атип) болон хорт хавдар (өндөр түвшинт дисплази, аденокарцинома, сигнет эсийн хорт хавдар гэх мэт)-ыг илрүүлэх зорилгоор олон төвт ретроспектив судалгааг хийсэн. (Улаанбаатар хотын 9 дүүрэг, 21 аймгийн дурангийн төвүүд). Энэхүү судалгааны үндсэн үр дүн нь эрт илрүүлэлтийн түвшинг тодорхойлох (эндоскопийн шинжилгээнд хамрагдсан хүмүүсийн эерэг тохиолдлын эзлэх хувь), хорт хавдрын төрөл, түүний дотор түүний урьдал өвчний шинж чанарыг тодорхойлох явдал байв. Үр дүн: Бидний судалгаанд 2022 оны 5 дугаар сараас 2023 оны 5 дугаар сар хүртэл нийт 67634 хүн хамрагдсанаас дурангийн шинжилгээгээр 402 буюу нийт хүмүүсийн 0.5% нь ходоодны хорт хавдартай гэж оношлогдсон байна. Ходоодны хорт хавдрын эрт үе шатанд өвчлөгсдийн эзлэх хувь 56.9% байна. Дүгнэлт: 1. Ходоодны хавдрын бус өөрчлөлтийн хувьд эдийн шинжилгээнд бага түвшинт дисплази өөрчлөлт давамгай илэрч байна 2. Ходоод-улаан хоолойн хорт хавдраас урьдчилан сэргийлэх үндэсний хөтөлбөрийг эхлүүлсэн нь ходоодны хорт хавдрыг эрт үед нь илрүүлэх, эмчлэх боломжийг тогтоосноор ходоодны хорт хавдрын шалтгаант нас баралтыг бууруулах ач холбогдолтой байгаа нь уг хөтөлбөрийг тасралтгүй хэрэгжүүлэх шаардлагатайг харуулж байна. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Study of Helicobacter pylori Isolated from a High-Gastric-Cancer-Risk Population: Unveiling the Comprehensive Analysis of Virulence-Associated Genes including Secretion Systems, and Genome-Wide Association Study(MDPI AG, 2023-09); ;Alfaray, Ricky Indra; ; Khangai, AyushBACKGROUND: The prevalence of gastric cancer in Mongolia, in East Asia, remains the highest in the world. However, most Helicobacter pylori strains in Mongolia have a less virulent Western-type CagA. We aimed to determine how H. pylori genomic variation affected gastric diseases, especially gastric cancer, based on comprehensive genome analysis. METHODS: We identified a set of 274 virulence-associated genes in H. pylori, including virulence factor and outer membrane protein (OMP) genes, the type four secretion system gene cluster, and 13 well-known virulence gene genotypes in 223 H. pylori strains and their associations with gastric cancer and other gastric diseases. We conducted a genome-wide association study on 158 H. pylori strains (15 gastric cancer and 143 non-gastric cancer strains). RESULTS: Out of 274 genes, we found 13 genes were variable depending on disease outcome, especially iron regulating OMP genes. H. pylori strains from Mongolia were divided into two main subgroups: subgroup (Sg1) with high risk and Sg2 with low risk for gastric cancer. The general characteristics of Sg1 strains are that they possess more virulence genotype genes. We found nine non-synonymous single nucleotide polymorphisms in seven genes that are linked with gastric cancer strains. CONCLUSIONS: Highly virulent H. pylori strains may adapt through host-influenced genomic variations, potentially impacting gastric carcinogenesis.Scopus© Citations 10 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during Helicobacter pylori Infection(The Editorial Office of Gut and Liver, 2024-01) ;Khangai, Ayush ;Akada, Junko; ; Azzaya, DashdorjBACKGROUND/AIMS: : A latex agglutination turbidity (LA) assay to test for serum antibodies has been approved in Japan and Korea for mass screening of Helicobacter pylori infection. In this study, we evaluated the LA assay for diagnosing H. pylori infection and predicting gastric mucosal changes in a Mongolian population. METHODS: : In total, 484 individuals were classified into H. pylori-positive (n=356) and H. pylori-negative (n=128) groups, as determined by histology and H. pylori culture. RESULTS: : The best cutoff, sensitivity, and specificity values for the LA assay were 18.35 U/mL, 74.2%, and 65.6%, respectively. The LA values in the atrophic gastritis group were statistically higher than those in the other groups (healthy, chronic gastritis, intestinal metaplasia, and gastric cancer, p<0.0001). The cutoff value to distinguish the atrophic gastritis group from the other four groups was 32.0 U/mL, and its area under the curve was 0.673, which was the highest among the E-plate, pepsinogen (PG) I, PG II, and PG I/II ratio tests in our data. The odds ratios for atrophic gastritis determined by the LA assay and PG I test in multiple logistic regression were 2.5 and 1.9, respectively, which were significantly higher than for the other tests. CONCLUSIONS: : The LA assay can determine the risk of atrophic gastritis, which in turn is a considerable risk factor for gastric cancer. We propose using this assay in combination with the PG I/II ratio to avoid missing gastric cancer patients who have a low LA value (less than 32.0 U/mL).Scopus© Citations 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, High Antibiotic Resistance of Helicobacter pylori and Its Associated Novel Gene Mutations among the Mongolian Population(MDPI AG, 2020-07) ;Azzaya, Dashdorj; ; ; Matsumoto, TakashiMongolia has a high prevalence of Helicobacter pylori infection and the second highest incidence of gastric cancer worldwide. Thus, investigating the prevalence of antibiotic resistance and its underlying genetic mechanism is necessary. We isolated 361 H. pylori strains throughout Mongolia. Agar dilution assays were used to determine the minimum inhibitory concentrations of five antibiotics; amoxicillin, clarithromycin, metronidazole, levofloxacin, and minocycline. The genetic determinants of antibiotic resistance were identified with next-generation sequencing (NGS) and the CLC Genomics Workbench. The resistance to metronidazole, levofloxacin, clarithromycin, amoxicillin, and minocycline was 78.7%, 41.3%, 29.9%, 11.9% and 0.28%, respectively. Multidrug resistance was identified in 51.3% of the isolates investigated which were further delineated into 9 antimicrobial resistance profiles. A number of known antibiotic resistance mutations were identified including rdxA, frxA (missense, frameshift), gyrA (N87K, A88P, D91G/N/Y), 23S rRNA (A2143G), pbp1A (N562Y), and 16S rRNA (A928C). Furthermore, we detected previously unreported mutations in pbp1A (L610*) and the 23S rRNA gene (A1410G, C1707T, A2167G, C2248T, and C2922T). The degree of antibiotic resistance was high, indicating the insufficiency of standard triple therapy in Mongolia.Scopus© Citations 36
